Industry Shares How Far It’s Come on Transparency After Concerns Raised

Clinical Trials Advisor
A A
The pharmaceutical industry is becoming more active in sharing clinical trial data in a way that may have seemed inconceivable 20 years ago, drugmakers said, even as it has taken heat for being opaque on disclosures.

To View This Article:

Login

Subscribe To Clinical Trials Advisor